Arriving in the landscape of excess body fat management, retatrutide represents a different strategy. Different from many existing medications, retatrutide functions as a dual agonist, concurrently targeting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) binding sites. The dual activation fosters various benefici… Read More